ResultsIQ

ResultsIQ › Latest results › Godrej Agrovet Limited

Godrej Agrovet Limited Q4 FY26 results deck summary

NSE: GODREJAGRO · BSE: 540743

Results deck of 30 Apr 2026, summarised by AI from the filing.

Revenue from operations ₹10,233 cr (FY25: ₹9,383 cr, +9.1%), with PAT ₹440 cr (FY25: ₹386 cr, +13.9%)

Key takeaways

  1. FY26 revenue Revenue from operations ₹10,233 cr (FY25: ₹9,383 cr, +9.1%), with PAT ₹440 cr (FY25: ₹386 cr, +13.9%)
  2. Dairy margin Creamline Dairy FY26 EBITDA fell to ₹53 cr (FY25: ₹79 cr, -33.0%) on elevated milk procurement prices

Original filing on BSE

Godrej Agrovet Limited Q1 FY27 results

As filed: Revenue ₹2,855 cr (+9% year on year), EBITDA ₹240 cr (−11% year on year), PAT ₹128 cr (−14% year on year), EBITDA margin 8.4% (−188 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹2,333 cr (+9% year on year), EBITDA ₹139 cr (−5% year on year), PAT ₹102 cr (+55% year on year), EBITDA margin 6.0% (−89 bps). Score 38 of 100, Below trend. Revenue growth was well above the company's own trend; EBITDA growth was below it; profit growth was above it. EBITDA margin fell 89 bps year on year. Other income 56% of PBT. Consolidated profit +55% but standalone -5%. Revenue fell 14% from last quarter. Share price after the results: −3.4% in 29 days (Nifty 500: −0.1%).
  • Q3 FY26: Revenue ₹2,718 cr (+11% year on year), EBITDA ₹242 cr (+10% year on year), PAT ₹110 cr (+23% year on year), EBITDA margin 8.9% (−9 bps). Score 60 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was below it; profit before exceptional items growth was in line with it. EBITDA margin was flat year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +11.2% in 30 days (Nifty 500: −3.2%).
  • Q2 FY26: Revenue ₹2,567 cr (+5% year on year), EBITDA ₹214 cr (−4% year on year), PAT ₹84.0 cr (−13% year on year), EBITDA margin 8.3% (−77 bps). Score 31 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 77 bps year on year. Tax rate 41%. Consolidated profit -12% but standalone +34%. Profit fell 44% from last quarter. Share price after the results: −10.2% in 30 days (Nifty 500: +0.7%).
  • Q1 FY26: Revenue ₹2,614 cr (+11% year on year), EBITDA ₹269 cr (+19% year on year), PAT ₹149 cr (+13% year on year), EBITDA margin 10.3% (+64 bps). Score 62 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was below it; profit growth was in line with it. EBITDA margin rose 64 bps year on year. Share price after the results: −7.6% in 30 days (Nifty 500: +0.1%).
  • Q4 FY25: Revenue ₹2,134 cr (0% year on year), EBITDA ₹146 cr (−1% year on year), PAT ₹66.0 cr (+2% year on year), EBITDA margin 6.8% (−9 bps). Score 35 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was well below it; profit growth was below it. EBITDA margin was flat year on year. Revenue fell 13% from last quarter. Share price after the results: −1.0% in 30 days (Nifty 500: +3.5%).
  • Q3 FY25: Revenue ₹2,450 cr (+4% year on year), EBITDA ₹220 cr (+38% year on year), PAT ₹110 cr (+33% year on year), EBITDA margin 9.0% (+220 bps). Score 67 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin rose 220 bps year on year.
  • Q2 FY25: Revenue ₹2,449 cr (−5% year on year), EBITDA ₹223 cr (+10% year on year), PAT ₹96.0 cr (−8% year on year), EBITDA margin 9.1% (+125 bps). Score 32 of 100, Below trend. EBITDA margin rose 125 bps year on year. Tax rate 39%. Not enough history for a trend yet: scored on growth alone. Profit fell 27% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Godrej Agrovet Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.